Traders Purchase Large Volume of Call Options on Tilray (NASDAQ:TLRY)

Tilray Inc (NASDAQ:TLRY) saw unusually large options trading on Tuesday. Traders purchased 65,869 call options on the stock. This represents an increase of 67% compared to the typical daily volume of 39,407 call options.

Analysts Set New Price Targets

Separately, Roth Mkm lowered their price target on Tilray from $2.00 to $1.75 and set a “neutral” rating on the stock in a research note on Friday, October 11th.

Institutional Trading of Tilray

A number of institutional investors and hedge funds have recently added to or reduced their stakes in TLRY. Private Advisor Group LLC grew its position in Tilray by 7.3% in the 1st quarter. Private Advisor Group LLC now owns 175,845 shares of the company’s stock valued at $434,000 after acquiring an additional 12,021 shares in the last quarter. Swiss National Bank grew its holdings in shares of Tilray by 3.6% in the first quarter. Swiss National Bank now owns 1,490,938 shares of the company’s stock valued at $3,683,000 after purchasing an additional 51,700 shares in the last quarter. Concurrent Investment Advisors LLC purchased a new position in Tilray in the 1st quarter valued at approximately $75,000. Headlands Technologies LLC acquired a new position in shares of Tilray in the first quarter worth $216,000. Finally, Avantax Advisory Services Inc. boosted its holdings in Tilray by 46.2% in the first quarter. Avantax Advisory Services Inc. now owns 53,110 shares of the company’s stock valued at $131,000 after purchasing an additional 16,792 shares during the period. Hedge funds and other institutional investors own 9.35% of the company’s stock.

Tilray Trading Up 5.0 %

TLRY stock opened at $1.47 on Wednesday. Tilray has a 12 month low of $1.36 and a 12 month high of $2.97. The company has a current ratio of 2.47, a quick ratio of 1.57 and a debt-to-equity ratio of 0.08. The firm has a 50-day moving average of $1.66 and a two-hundred day moving average of $1.78.

Tilray (NASDAQ:TLRY) last posted its earnings results on Thursday, October 10th. The company reported ($0.04) earnings per share for the quarter, meeting the consensus estimate of ($0.04). The company had revenue of $200.00 million for the quarter, compared to analyst estimates of $218.70 million. Tilray had a negative net margin of 26.79% and a negative return on equity of 2.00%. Tilray’s revenue was up 13.0% on a year-over-year basis. During the same period in the previous year, the business posted ($0.10) EPS. As a group, equities research analysts expect that Tilray will post -0.14 EPS for the current fiscal year.

Tilray Company Profile

Tilray, Inc engages in the research, cultivation, processing, and distribution of medical cannabis. The company offers its products in Argentina, Australia, Canada, Chile, Croatia, Cyprus, the Czech Republic, Germany, New Zealand, and South Africa. Tilray, Inc is headquartered in Canada.